Angiosarcoma of the Scalp and Face: A Hard to Treat Tumor
Journal Title: Global Journal of Cancer Therapy - Year 2017, Vol 3, Issue 1
Abstract
Cutaneous angiosarcoma is a rare and aggressive malignant tumor of vascular origin. Multimodality treatment including surgery, radiotherapy and chemotherapy should be used according to age and local spread. Prognosis is poor with a 5-year survival of 10-15%. We report the case of an angiosarcoma of the scalp and face treated with sequential contact radiotherapy and chemotherapy. After local response, the patient progressed in non-irradiated zone then had liver metastasis.
Authors and Affiliations
Jmour Omar, Kochbati Lotfi, Ghith Sahar, Benna Farouk
Keywords
Related Articles
- EP ID EP353656
- DOI 10.17352/2581-5407.000018
- Views 64
- Downloads 0
Video Endoscopic Inguinal Lymphadenectomy: Refining surgical technique after ten years experience
Penile carcinoma is a rare malignant disease with a significantly higher incidence in some areas of under- developed countries [1]. Inguinal nodal involvement is found in 20% to 40% of cases at diagnosis and nodal metast...
Gamma-Delta T Cell Acute Lymphoblastic Leukemia: A Single-Center Experience
Gamma-delta (γδ) T cell neoplasms are a rare disease entity characterized by an aggressive clinical course [1,2]. The management of these neoplasms associated with high incidence of induction failures and poor clinical o...
An Overview of Thyroid Cancer Genetics and Inheritance
Thyroid cancer (TC) is the most common endocrine malignancy and its incidence hasbeen increasing sharply since the mid-1990s [1]. TC is a general term that comprises two main groups of neoplasias, depending on the cell t...
Genetic Polymorphisms and Cisplatin- Related Nephrotoxicity
Cisplatin is one of the most widely applied antineoplastic agents used to treat different types of solid tumours. However, its use is limited by serious side- effects including nephrotoxicity. Cisplatin accumulates in pr...
A Novel Small-Molecule Integrin Antagonist Inhibits Cells Adhesion Followed By Anoikis in Endothelial Cells - A Comparative Analysis with Cilengitide
Background: Despite the crucial role of integrin receptors in cancer pathogenesis and massive efforts towards establishing clinically relevant drugs, to the present no effective integrin antagonist for the treatment of m...